Resources
Home
/
Resources
-
Drug Delivery Innovations for CEPI’s 100 Days Mission
Speaker Presentation Patel Dimki CEPI 2024 -
An Industry Perspective on the Use of Forced Degradation Studies to Assess Comparability of Biopharmaceuticals
Speaker Presentation Nowinski Ann (Kasia) Pfizer, Inc. 2024
-
From Blur to Clarity: Definition of Particle VisibilityThreshold in Parenteral Drug Products
Speaker Presentation Nikels Felix Boehringer Ingelheim Pharma GmbH & Co. KG and Koulov Atanas Clear Solutions Laboratories 2024
-
A Journey Through the Biopharmaceutical Industry
Speaker Presentation Miller Ken BioMarin Pharmaceutical Inc. 2024
-
Building a Comparability Strategy for a Major Post-Approval Manufacturing Change
Speaker Presentation McKnight Nathan Genentech, a Member of the Roche Group 2024
-
Considerations for Animal Use and Sustainability
– A Regulatory Perspective
Speaker Presentation Levis Robin CBER, FDA 2024
-
Intro to Bayesian and Frequentist Statistics
Speaker Presentation Kirk Jennifer CBER, FDA 2024
-
Could ADCs be the Drug Equivalent of Lego®?
Speaker Presentation Ihle Nathan Bolt Biotherapeutics and Krantz Carol Pfizer Inc. 2024
-
Platform Analytical Procedures – Applying Concepts in ICH Q2(R2) and ICH Q14
Speaker Presentation Finkler Christof F. Hoffman-La Roche Ltd. and Viswanathan Balaji Pfizer, Inc. 2024
-
Designing and Manufacturing Medicines with Sustainability at the Core
Speaker Presentation Dell'orco Philip GlaxoSmithKline 2024
-
Enhanced Quality Attribute Understanding to Enable Accelerated Development of an RSV Vaccine
Speaker Presentation Davis John Pfizer, Inc. 2024
-
Visual Inspection & Particle LCM for CGT Products
Speaker Presentation Burazer Antonio Takeda Austria GmbH 2024
-
From Blood-brain Barrier to Blood-brain Interface: Strategies for Drug Delivery to the Brain
Speaker Presentation Banks Bill University of Washington 2024
-
Update From WHO: Global Perspective on Regulatory Harmonization and Convergence to Support Reliance
Speaker Presentation Azatyan Samvel World Health Organization 2024
-
WCBP 2024 Scientific Program
Scientific Program: WCBP 2024
-
WCBP 2024 Summary Infographic
Summary Infographic: WCBP 2024
-
Patient and User Centric Considerationson In-Use Study Design
Speaker Presentation Weiser Sarah Pfizer, Inc. 2024 -
Leveraging Platforms to Accelerate ADC Formulation and Drug Product Development
Speaker Presentation Rutherford Karen Seagen, Inc. 2024
-
Leveraging Prior Knowledge for Practical Application of Platform Analytical Procedures in Late-Stage Development of Monoclonal Antibodies
Speaker Presentation Patel Hetal Pfizer, Inc. 2024
-
Pharmaceutical Industry Perspective on Closed System Transfer Devices (CSTDs): Balancing Overfill, Evaluating, Communicating
Speaker Presentation Lehermayr Christian Novartis Pharma AG 2024